6 May 2021
Biotechnological discovery of Brno scientists patented in Singapore
Fibroblast growth factor FGF2-STAB, which was developed at MUNI, has now been patented, not just in Europe but also in Singapore, with patent proceedings also ongoing in a number of other countries. The patent is shared between Masaryk University and the university spin-off ‘Enantis’, which is in charge of the commercial use of the growth factor molecule. The discovery will have applications in cell biology, regenerative medicine and cosmetics.